We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 4,100 results
  1. Papillary Thyroid Carcinoma Methods and Protocols

    This detailed volume presents status and management protocols with the objective of identifying proper guidelines and materials for research related...
    Alfred K. Lam in Methods in Molecular Biology
    Book 2022
  2. KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation

    Despite many studies on papillary thyroid carcinoma (PTC) in the past few decades, some critical and significant genes remain undiscovered. To...

    Tao Ni, Ru-hua Zhao, ... Xu Lin in Biochemical Genetics
    Article 05 February 2024
  3. Impact of age on central lymph nodes involvement in papillary thyroid cancer

    Background

    Total thyroidectomy is the main line of treatment for papillary thyroid cancer. Central lymph node dissection (CLND) is still debatable. In...

    Shadi Awny, Ahmed Abdallah, ... Khalid Atallah in BMC Cancer
    Article Open access 05 April 2024
  4. Histological Variants of Papillary Thyroid Cancer in Relation to Clinical and Morphological Parameters and Prognosis

    The correlation of histological features of papillary thyroid cancer with clinical and morphological prognostic factors and cause-specific mortality...

    A. A. Ivanov, M. A. Bakarev, E. L. Lushnikova in Bulletin of Experimental Biology and Medicine
    Article 01 March 2023
  5. TET1 is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Papillary Thyroid Cancer

    To investigate the function of ten-eleven translocation 1 (TET1) and its underlying mechanism in papillary thyroid cancer (PTC). Using the RNA-Seq...

    Yong-xun Zhao, Li-bin Ma, ... Cheng **ang in Biochemical Genetics
    Article 06 July 2023
  6. Histopathological Assessment for Papillary Thyroid Carcinoma

    Histologic assessments of papillary thyroid carcinoma are crucial for management of patients with the cancer as well as research on the cancer as...
    Alfred K. Lam in Papillary Thyroid Carcinoma
    Protocol 2022
  7. The Long Non-Coding RNA ENST00000494165 Influence Papillary Thyroid Cancer Cell Proliferation and Invasion

    Long noncoding RNAs (lncRNAs) have recently been identified as crucial biomarkers of papillary thyroid cancer (PTC). In this study, we aimed to...

    Wenhan Wang, Shujun **a, ... Weiwei Zhan in Cytology and Genetics
    Article 25 September 2023
  8. Identification of Chimeric NTRK3 Genes in Papillary Thyroid Cancer Cells by Analyzing the Imbalance of the Expression of 5’ and 3’ mRNA Fragments

    The standard for detecting chimeric genes of neurotrophic receptor tyrosine kinases ( NTRK ) is next generation sequencing (NGS). However, this...

    I. P. Oskorbin, A. A. Ivanov, ... M. L. Filipenko in Bulletin of Experimental Biology and Medicine
    Article 01 June 2023
  9. Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features

    Background

    Thyroid cancer is prevalent worldwide, including in China, where its incidence is on the rise. Papillary thyroid carcinoma (PTC) is the...

    Qiang Wang, Bo Yu, ... Dewei Li in Molecular Diagnosis & Therapy
    Article Open access 19 June 2024
  10. Elucidating the role of Pyroptosis in papillary thyroid cancer: prognostic, immunological, and therapeutic perspectives

    Background

    Pyroptosis, an inflammatory form of programmed cell death, has been implicated in the pathogenesis and progression of several cancers....

    Fang Li, Rui Du, ... Nan Liang in Cancer Cell International
    Article Open access 29 January 2024
  11. Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer

    Papillary thyroid cancer (PTC) is the most frequent subtype of thyroid cancer, but 20% of cases are indeterminate (i.e., cannot be accurately...

    Guochao Ye, **aomei Zhang, ... Xu Qian in BMC Cancer
    Article Open access 08 May 2023
  12. Thyroidectomy for Papillary Thyroid Carcinoma

    Papillary thyroid carcinoma is the most common endocrine malignancy and accounts for the overwhelming majority of thyroid carcinoma. This recent...
    Chung Yau Lo in Papillary Thyroid Carcinoma
    Protocol 2022
  13. CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis

    Background

    Although papillary thyroid carcinoma (PTC) has a favorable prognosis, it could affect patient life quality and become a serious threat...

    Jiying Shen, Zhirong Ma, ... Weiwei Liu in BMC Cancer
    Article Open access 23 April 2024
  14. Thyroid Cancer: Quantum MicroRNA Language/Artificial Intelligence (MIRAI)-Based Etiologic Analysis of Thyroid Cancer by Serum/Plasma miRNA Panel Data

    We have previously demonstrated that cancer pathogenesis can be simulated in silico by using a panel of circulating microRNAs (miRNAs) as biomarkers....
    Yoichi Robertus Fujii in The MicroRNA Quantum Code Book
    Chapter 2023
  15. Application of Immunohistochemistry in Papillary Thyroid Carcinoma

    Immunohistochemistry (IHC) is an economic and precise method to localize the presence of specific protein at cellular level in tissue. Although many...
    Alfred K. Lam, Katherine Ting-Wei Lee in Papillary Thyroid Carcinoma
    Protocol 2022
  16. Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches

    Background

    Although papillary thyroid cancer (PTC) patients are known to have an excellent prognosis, up to 30% of patients experience disease...

    Hongxi Wang, Chao Zhang, ... Rong Tian in BMC Cancer
    Article Open access 08 April 2024
  17. Papillary Thyroid Carcinoma: Current Position in Epidemiology, Genomics, and Classification

    Papillary thyroid carcinoma is the most common type of thyroid malignancy both in adults and pediatric population. Since the 1980s, there are changes...
    Alfred K. Lam in Papillary Thyroid Carcinoma
    Protocol 2022
  18. A nomogram for predicting adverse pathologic features in low-risk papillary thyroid microcarcinoma

    Background

    Identifying risk factors for adverse pathologic features in low-risk papillary thyroid microcarcinoma (PTMC) can provide valuable insights...

    Lei Gong, ** Li, ... Kai Liang in BMC Cancer
    Article Open access 22 February 2024
  19. CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?

    We report the case of a breast cancer survivor, diagnosed with an underlying CHEK2 c.1100delC heterozygosity, who developed a papillary thyroid...

    Kortbeek Koen, De Putter Robin, Naert Eline in Hereditary Cancer in Clinical Practice
    Article Open access 31 January 2022
Did you find what you were looking for? Share feedback.